Susquehanna Fundamental Investments’s 89bio ETNB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-212,522	Closed	-$3.12M	–	610
2025 Q3	$3.12M	Sell	212,522 -43,274	-17%	-$441K	0.12%	189
2025 Q2	$2.51M	Sell	255,796 -10,670	-4%	-$88.3K	0.07%	296
2025 Q1	$1.94M	Buy	266,466 +205,474	+337%	+$1.8M	0.03%	534
2024 Q4	$477K	Buy	+60,992	New	+$502K	0.01%	864

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna Fundamental Investments's ETNB Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of 89bio (ETNB) in Q4 2025, closing a stake of 212,522 shares — an estimated $3.12M sold.

Susquehanna Fundamental Investments first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $3.12M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Susquehanna Fundamental Investments reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 212,522 89bio shares in Q4 2025, an estimated $3.12M.
Susquehanna Fundamental Investments first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
Susquehanna Fundamental Investments's 89bio position peaked at $3.12M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.